ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 682

Impact of Patient’s Priorities on the Management of Systemic Lupus Erythematosus

Valérie Leclair1, Holly O. Witteman2, Carolyn Neville3, Isabelle Fortin4 and Paul R. Fortin5, 1Internal Medicine, Laval University, Department of Internal Medicine, Quebec City, QC, Canada, 2Medicine, Laval University, Family and Emergency Medicine, Quebec City, QC, Canada, 3Epidemiology, Division of Clinical Epidemiology, Department of Medicine, McGill University Health Centre, Canada, Montreal, QC, Canada, 4Centre de Rhumatologie de l'Est du Québec, Rimouski, QC, Canada, 5Rheumatology, Laval University, Division of Rheumatology, Centre de Recherche du CHU de Québec and Department of Medicine, Quebec City, QC, Canada

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: management, Quality of life and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Treatment and Management Studies

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Systemic Lupus Erythematosus (SLE) greatly reduces the quality of life (QoL) and satisfaction with life of affected patients. SLE patients can have numerous unmet needs and may feel misunderstood by their health care providers. The aim of this study was to explore what is important to SLE patients when it comes to their care.

Methods:

Participants were adults satisfying the ACR classification for SLE, and were  recruited by phone, letter or directly by their respective rheumatologist. A qualitative approach based on audio-recorded focus groups was used to collect data.  Interview guides were prepared prior to the meetings by an expert panel including: a resident in internal medicine, a psychologist, a rheumatologist, and nurse. The open-ended questions covered SLE patient priorities, their means of conveying these priorities to their medical team, and the impact of these priorities on their disease management. The transcriptions were independently coded by 2 analysts using 2 techniques: 1) a qualitative data analysis software (NVivo 10) and 2) manual analysis. The analytic approach was based on grounded theory.

Results:

Nineteen female participants attended 3 focus groups in 2 sites (university and community-based). Participants’ ages ranged from 18 to >70 with the majority between 30 and 59 years of age. The average disease duration was 8.8 ± 7,7 years, ranging from 1 to 23 years. 68% were married/or cohabitating with a partner and 63% were employed.  Five priorities (Figure 1) were identified: 1) management of disability, in particular, loss of energy that prevents full engagement in daily activities, relationships, and social roles; 2) management of the unpredictable nature of SLE including, preventing flares and worsening of their condition, employment and financial issues associated with chronicity; 3) management of side effects; 4) access to information about lupus and support resources, in particular, support groups; 5) access to health care (improved communication between physicians, shorter wait times and longer consultations with physicians).  

Conclusion:

SLE patients have multiple complex priorities and may have difficulty articulating them. Health care providers need to develop strategies and communication tools to help SLE patients identify their priorities and support them in the self-management of their disease.

Figure 1 Priorities of SLE patients

Description : Macintosh HD:Users:valerieleclair:Desktop:ojk.png


Disclosure:

V. Leclair,
None;

H. O. Witteman,
None;

C. Neville,
None;

I. Fortin,

Janssen Inc.,

5;

P. R. Fortin,

GSK International,

9.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-patients-priorities-on-the-management-of-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology